New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has...
from NDTV News - Topstories https://ift.tt/2Rhj5P9
Friday, September 11, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment